Peripheral antinociception by carbamazepine in an inflammatory mechanical hyperalgesia model in the rat: A new target for carbamazepine?

Journal of Pharmacological Sciences

Volumn 100, Issue 4, 2006, Pages 310-314

  Vučković, Sonja ^a   Tomić, Maja ^a   Stepanović Petrović, Radica ^a   Ugrešić, Nenad ^a   Prostran, Milica ^a   Bošković, Bogdan ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Adenosine A1 receptor; Inflammatory mechanical hyperalgesia; Local carbamazepine

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; CAFFEINE; CARBAMAZEPINE; CONCANAVALIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG TARGETING; HINDLIMB; HYPERALGESIA; MALE; NONHUMAN; RAT;

EID: 33645845731     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.SCE05003X     Document Type: Article

References (15)

1. Ambrosio AF, Soares-da-Silva P, Carvalho CM, Carvalho AP. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res. 2002;27:121-130.
2. Fox A, Gentry C, Patel S, Kesingland A, Bevan S. Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig. Pain. 2003;105:355-362.
3. Kiguchi S, Imamura T, Ichikawa K, Kojima M. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy. Clin Exp Pharmacol Physiol. 2004;31:57-64.
4. Tomić MA, Vučković SM, Stepanović-Petrović RM, Ugrešić N, Prostran MS, Bošković B. The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain. 2004;111:253-260.
5. Sakaue A, Honda M, Tanabe M, Ono H. Antinociceptive effects of sodium channel-blocking agents on acute pain in mice. J Pharmacol Sci. 2004;95:181-188.
6. Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol. 2003;69:313-340.
7. 2) receptors. Psychopharmacology. 1986;90:332-335.
8. Mashimoto S, Ushijima I, Suetsugi M, Akimoto T, Watanabe K, Yamada M. Stress-dependent antinociceptive effects of carbamazepine: a study in stressed and nonstressed rats. Prog Neuropsychopharmacol Biol Psychiatry. 1998;22:159-168.
9. Vučković S, Prostran M, Ivanović M, Ristović Z, Stojanović R. Antinociceptive activity of the novel fentanyl analogue isocarfentanil in rats. Jpn J Pharmacol. 2000;84:188-195.
10. Tallarida RJ, Murray RB. Manual of pharmacologic calculations with computer programs. 2nd ed. New York, Berlin, Heidelberg, London, Paris, Tokyo: Springer Verlag; 1986.
11. Todorovic SM, Rastogi AJ, Jevtovic-Todorovic V. Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmacol. 2003;140:255-260.
12. Fredholm BB. Astra award lecture. Adenosine, adenosine receptors and the actions of caffeine. Pharmacol Toxicol. 1995;76:93-101.
13. Skeritt JH, Davies LP, Johnston GA. A purinergic component in the anticonvulsant action of carbamazepine? Eur J Pharmacol. 1982;82:195-197.
14. Phillis JW. Interactions of the anticonvulsants diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia. 1984;25:765-772.
15. 1 receptors very similar to those of peripheral tissues. Eur J Pharmacol. 1991;196:313-317.